Nine Point Two Capital LLC Castle Biosciences Inc Transaction History

Nine Point Two Capital LLC

  • $252 Million
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$16.0 - $45.99 $111,440 - $320,320
-6,965 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$39.06 - $67.58 $272,052 - $470,694
6,965 New
6,965 $298,000
Q3 2021

Nov 10, 2021
SELL
$60.13 - $77.6 $169,506 - $218,754
-2,819 Closed
0 $0
Q2 2021

Aug 05, 2021
BUY
$50.07 - $76.78 $141,147 - $216,442
2,819 New
2,819 $206,000

Others Institutions Holding CSTL

# of Institutions
162
Shares Held
25.3M
Call Options Held
82.2K
Put Options Held
150K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $559M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Nine Point Two Capital LLC Portfolio

Follow Nine Point Two Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Point Two Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nine Point Two Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email